|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0006674,
umls-concept:C0008972,
umls-concept:C0028912,
umls-concept:C0033860,
umls-concept:C0034656,
umls-concept:C0205081,
umls-concept:C0332307,
umls-concept:C0332461,
umls-concept:C0439272,
umls-concept:C0547040,
umls-concept:C1273870,
umls-concept:C1274040
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-8-2
|
|
pubmed:abstractText |
Psoriasis is a chronic skin disorder affecting approximately 2% of the US population. Psoriasis may occur anywhere on the body with initial presentation usually seen between 15 and 30 years of age. Calcitriol 3 microg/g ointment has demonstrated good clinical efficacy as well as topical and systemic safety when used to treat psoriasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1545-9616
|
|
pubmed:author |
pubmed-author:BalinArthur KAK,
pubmed-author:ClarkScott DSD,
pubmed-author:FlemingThomasT,
pubmed-author:FloresJavierJ,
pubmed-author:GlinertRobert JRJ,
pubmed-author:GraeberMichaelM,
pubmed-author:KempersStevenS,
pubmed-author:LebwohlMarkM,
pubmed-author:LiuYinY,
pubmed-author:MenterAlanA,
pubmed-author:PariserDavid MDM,
pubmed-author:PowersJeroldJ,
pubmed-author:WeissJonathanJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
428-35
|
|
pubmed:meshHeading |
pubmed-meshheading:17668541-Administration, Cutaneous,
pubmed-meshheading:17668541-Adolescent,
pubmed-meshheading:17668541-Adult,
pubmed-meshheading:17668541-Aged,
pubmed-meshheading:17668541-Aged, 80 and over,
pubmed-meshheading:17668541-Calcitriol,
pubmed-meshheading:17668541-Calcium,
pubmed-meshheading:17668541-Double-Blind Method,
pubmed-meshheading:17668541-Drug Administration Schedule,
pubmed-meshheading:17668541-Erythema,
pubmed-meshheading:17668541-Female,
pubmed-meshheading:17668541-Humans,
pubmed-meshheading:17668541-Male,
pubmed-meshheading:17668541-Middle Aged,
pubmed-meshheading:17668541-Ointments,
pubmed-meshheading:17668541-Psoriasis,
pubmed-meshheading:17668541-Serum Albumin,
pubmed-meshheading:17668541-Severity of Illness Index,
pubmed-meshheading:17668541-Skin,
pubmed-meshheading:17668541-Time Factors,
pubmed-meshheading:17668541-Treatment Outcome,
pubmed-meshheading:17668541-Vitamins
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
|
|
pubmed:affiliation |
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
